253 related articles for article (PubMed ID: 17059795)
1. Surgical risk in patients with metabolic syndrome: focus on lipids and hypertension.
Watson K
Curr Cardiol Rep; 2006 Nov; 8(6):433-8. PubMed ID: 17059795
[TBL] [Abstract][Full Text] [Related]
2. Operative risk factors in the metabolic syndrome: is it lipids and high blood pressure or are there direct vascular effects of insulin resistance and obesity?
Ukkola O
Curr Cardiol Rep; 2006 Nov; 8(6):427-32. PubMed ID: 17059794
[TBL] [Abstract][Full Text] [Related]
3. Managing cardiometabolic risk: an evolving approach to patient care.
Watson K
Crit Pathw Cardiol; 2007 Mar; 6(1):5-14. PubMed ID: 17667880
[TBL] [Abstract][Full Text] [Related]
4. Drug treatment of metabolic syndrome.
Altabas V
Curr Clin Pharmacol; 2013 Aug; 8(3):224-31. PubMed ID: 22950955
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome, a cardiovascular disease risk factor: role of adipocytokines and impact of diet and physical activity.
Robinson LE; Graham TE
Can J Appl Physiol; 2004 Dec; 29(6):808-29. PubMed ID: 15630152
[TBL] [Abstract][Full Text] [Related]
6. The metabolic syndrome: diagnosis and treatment.
Zieve FJ
Clin Cornerstone; 2004; 6 Suppl 3():S5-13. PubMed ID: 15707265
[TBL] [Abstract][Full Text] [Related]
7. The metabolic syndrome and endothelial dysfunction: common highway to type 2 diabetes and CVD.
Diamant M; Tushuizen ME
Curr Diab Rep; 2006 Aug; 6(4):279-86. PubMed ID: 16879779
[TBL] [Abstract][Full Text] [Related]
8. The expanding scope of the metabolic syndrome and implications for the management of cardiovascular risk in type 2 diabetes with particular focus on the emerging role of the thiazolidinediones.
Greenberg AS
J Diabetes Complications; 2003; 17(4):218-28. PubMed ID: 12810246
[TBL] [Abstract][Full Text] [Related]
9. Potential contribution of metformin to the management of cardiovascular disease risk in patients with abdominal obesity, the metabolic syndrome and type 2 diabetes.
Després JP
Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S53-61. PubMed ID: 14502101
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology and therapeutics of cardiovascular disease in metabolic syndrome.
Wang Y; Yu Q; Chen Y; Cao F
Curr Pharm Des; 2013; 19(27):4799-805. PubMed ID: 23323622
[TBL] [Abstract][Full Text] [Related]
11. The pharmacological management of metabolic syndrome.
Rask Larsen J; Dima L; Correll CU; Manu P
Expert Rev Clin Pharmacol; 2018 Apr; 11(4):397-410. PubMed ID: 29345505
[TBL] [Abstract][Full Text] [Related]
12. What is the metabolic syndrome? Prediabetes and cardiovascular risk.
Borgman M; McErlean E
J Cardiovasc Nurs; 2006; 21(4):285-90. PubMed ID: 16823282
[TBL] [Abstract][Full Text] [Related]
13. Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.
Ferdinand KC
J Cardiometab Syndr; 2006; 1(2):133-40. PubMed ID: 17679832
[TBL] [Abstract][Full Text] [Related]
14. [Different adipose tissue depots and metabolic syndrome in human].
Wang R; Li XN
Sheng Li Xue Bao; 2017 Jun; 69(3):357-365. PubMed ID: 28638930
[TBL] [Abstract][Full Text] [Related]
15. Searching for phytoinsulins as cardiovascular protector in metabolic syndrome.
Ji L; Xing W; Dong L; Gao F
Curr Pharm Des; 2013; 19(27):4848-58. PubMed ID: 23323618
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular and renal effects of weight reduction in obesity and the metabolic syndrome.
Cohen JB; Cohen DL
Curr Hypertens Rep; 2015 May; 17(5):34. PubMed ID: 25833456
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk associated with the metabolic syndrome.
Lindsay RS; Howard BV
Curr Diab Rep; 2004 Feb; 4(1):63-8. PubMed ID: 14764282
[TBL] [Abstract][Full Text] [Related]
18. Addressing the insulin resistance syndrome: a role for the thiazolidinediones.
Zimmet P
Trends Cardiovasc Med; 2002 Nov; 12(8):354-62. PubMed ID: 12536122
[TBL] [Abstract][Full Text] [Related]
19. Lifestyle modification and endothelial function in obese subjects.
Hamdy O
Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
[TBL] [Abstract][Full Text] [Related]
20. The cardiovascular continuum in Asia--a new paradigm for the metabolic syndrome.
Cheung BM
J Cardiovasc Pharmacol; 2005 Aug; 46(2):125-9. PubMed ID: 16044022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
